At LSI USA ’26, the panel “Medtech M&A: An Optimist’s Perspective on the Future of Medtech” brought together leaders from EY-Parthenon, Medtronic, Evercore, Vensana Capital, and Edwards Lifesciences to discuss the state of dealmaking, capital deployment, and strategic growth across the industry. The conversation made one point clear: medtech M&A 2026 is not simply about whether deal activity returns. It is about how capital gets deployed, which assets attract strategic attention, and what companies need to prove before they can become must-have acquisition targets.
Read the full article: Medtech M&A 2026: Key Trends Shaping the Next Wave of Medical Device Deals //
Source: https://www.lsiusasummit.com/news/medtech-ma-2026-key-trends-shaping-the-next-wave-of-medical-device-deals